Vanguard Group Inc Cryo Cell International Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Cryo Cell International Inc stock. As of the latest transaction made, Vanguard Group Inc holds 118,235 shares of CCEL stock, worth $605,363. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,235
Previous 116,956
1.09%
Holding current value
$605,363
Previous $872,000
13.65%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CCEL
# of Institutions
22Shares Held
1MCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$2.1 Million2.29% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$846,3360.81% of portfolio
-
Massmutual Trust CO Fsb111KShares$568,4990.02% of portfolio
-
Geode Capital Management, LLC Boston, MA45.2KShares$231,5770.0% of portfolio
-
Northern Trust Corp Chicago, IL36.7KShares$187,9850.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $43.6M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...